TY  - THES
N2  - The potential limitations of the use of D2cc as implemented in the EMBRACE protocol are recognized and evaluated against a localized method for determining dose constraints in brachytherapy (BT) treatment planning. This study seeks to better understand the normal tissue dose constraints for HDR BT in the treatment of locally advanced cervix cancer.
DO  - 10.6083/vt150k277
DO  - DOI
AB  - The potential limitations of the use of D2cc as implemented in the EMBRACE protocol are recognized and evaluated against a localized method for determining dose constraints in brachytherapy (BT) treatment planning. This study seeks to better understand the normal tissue dose constraints for HDR BT in the treatment of locally advanced cervix cancer.
T1  - Better identification of normal tissue dose constraints for use in high dose rate brachytherapy in the treatment of locally advanced cervical cancer
DA  - 2022
AU  - Choudrie, Sonam K.
L1  - https://digitalcollections.ohsu.edu/record/9734/files/Choudrie.Sonam.2022.pdf
PB  - Oregon Health and Science University
PY  - 2022
ID  - 9734
L4  - https://digitalcollections.ohsu.edu/record/9734/files/Choudrie.Sonam.2022.pdf
KW  - Treatment Outcome
KW  - Brachytherapy
KW  - Uterine Cervical Neoplasms
KW  - Chemoradiotherapy
TI  - Better identification of normal tissue dose constraints for use in high dose rate brachytherapy in the treatment of locally advanced cervical cancer
Y1  - 2022
L2  - https://digitalcollections.ohsu.edu/record/9734/files/Choudrie.Sonam.2022.pdf
LK  - https://digitalcollections.ohsu.edu/record/9734/files/Choudrie.Sonam.2022.pdf
UR  - https://digitalcollections.ohsu.edu/record/9734/files/Choudrie.Sonam.2022.pdf
ER  -